Screener
Bio-Rad Laboratories BIO Americas — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
FAQ
- What is Bio-Rad Laboratories's americas — net sales?
- Bio-Rad Laboratories (BIO) reported americas — net sales of $45.1M in Q1 2026.
- How has Bio-Rad Laboratories's americas — net sales changed year-over-year?
- Bio-Rad Laboratories's americas — net sales increased by 13.3% year-over-year, from $39.8M to $45.1M.
- What is the long-term trend for Bio-Rad Laboratories's americas — net sales?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's americas — net sales has grown at a 1.4% compound annual growth rate (CAGR), from $156.4M to $165.4M.
- What does americas — net sales mean?
- This metric represents the total revenue generated from the sale of clinical diagnostics and life science products within the North and South American geographic regions. It serves as a primary indicator of market penetration and demand for the company's specialized laboratory equipment and reagents in these territories. Tracking this figure helps investors assess regional growth trends and the effectiveness of local sales and distribution strategies.
Ask your AI about Bio-Rad Laboratories's americas — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude